细胞株Cell Lines 44-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV44
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID hiPSC clone 1
AC CVCL_V196
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/hiPSC_clone_1.pdf
CC From: Centro Principe Felipe; Valencia; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V197 ! hiPSC clone 4
CA Induced pluripotent stem cell
//
ID hiPSC clone 4
AC CVCL_V197
CC From: Centro Principe Felipe; Valencia; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V196 ! hiPSC clone 1
CA Induced pluripotent stem cell
//
ID hiPSC-16423 #6
AC CVCL_II80
RX PubMed=27789407;
CC From: Bioneer A/S; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID hiPSC117
AC CVCL_C971
SY HIPSC117
DR ISCR; 326
RX PubMed=19252477;
CC From: Samuel Lunenfeld Research Institute; Toronto; Canada.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID hiPSC121
AC CVCL_C972
SY HIPSC121
DR ISCR; 325
RX PubMed=19252477;
CC From: Samuel Lunenfeld Research Institute; Toronto; Canada.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID hiPSC122
AC CVCL_C973
SY HIPSC122
DR ISCR; 324
RX PubMed=19252477;
CC From: Samuel Lunenfeld Research Institute; Toronto; Canada.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HIRcB
AC CVCL_0300
SY HIRc-B
DR MCCL; MCC:0000191
RX PubMed=3312193;
CC Transfected with: HGNC; 6091; INSR.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0492 ! Rat1
CA Spontaneously immortalized cell line
//
ID HIRS-BM
AC CVCL_E060
SY HIRSBM
DR CLO; CLO_0051382
DR BioSample; SAMN03472192
DR RCB; RCB0978
RX PubMed=6328089;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 8,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E061 ! HIRS-PB
SX Female
CA Cancer cell line
//
ID HIRS-PB
AC CVCL_E061
RX PubMed=6328089;
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E060 ! HIRS-BM
SX Female
CA Cancer cell line
//
ID HISM
AC CVCL_F640
SY Human Intestinal Smooth Muscle
DR ATCC; CRL-1692
DR BioSample; SAMN03472822
WW http://www.atcc.org/support/faqs/40680/HISM%20ATCC%20CRL1692-1094.aspx
CC Discontinued: ATCC; CRL-1692; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HIT-T15
AC CVCL_0301
SY HIT T15; HIT.T15; HIT T-15; HITT15; HIT clone T15; HIT
DR BTO; BTO:0000627
DR CLO; CLO_0003758
DR MCCL; MCC:0000192
DR ATCC; CRL-1777
DR IZSLER; BS TCL 188
DR KCB; KCB 200828YJ
DR KCLB; 21777
RX PubMed=6270673;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-502.html
CC Doubling time: 33-34 hours (PubMed=6270673).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Transformed cell line
//
ID HITA1
AC CVCL_D363
SY Human Internal Thoracic A1
RX PubMed=11557739;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D364 ! HITA2
OI CVCL_D365 ! HITA4
OI CVCL_D366 ! HITA5
OI CVCL_D367 ! HITB2
OI CVCL_D368 ! HITB5
OI CVCL_D369 ! HITC1
OI CVCL_D370 ! HITC6
OI CVCL_D371 ! HITD1
OI CVCL_D372 ! HITD4
OI CVCL_D373 ! HITD5
OI CVCL_D374 ! HITD6
SX Male
CA Finite cell line
//
ID HITA2
AC CVCL_D364
SY Human Internal Thoracic A2
RX PubMed=11557739;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D363 ! HITA1
OI CVCL_D365 ! HITA4
OI CVCL_D366 ! HITA5
OI CVCL_D367 ! HITB2
OI CVCL_D368 ! HITB5
OI CVCL_D369 ! HITC1
OI CVCL_D370 ! HITC6
OI CVCL_D371 ! HITD1
OI CVCL_D372 ! HITD4
OI CVCL_D373 ! HITD5
OI CVCL_D374 ! HITD6
SX Male
CA Finite cell line
//
ID HITA4
AC CVCL_D365
SY Human Internal Thoracic A4
RX PubMed=11557739;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D363 ! HITA1
OI CVCL_D364 ! HITA2
OI CVCL_D366 ! HITA5
OI CVCL_D367 ! HITB2
OI CVCL_D368 ! HITB5
OI CVCL_D369 ! HITC1
OI CVCL_D370 ! HITC6
OI CVCL_D371 ! HITD1
OI CVCL_D372 ! HITD4
OI CVCL_D373 ! HITD5
OI CVCL_D374 ! HITD6
SX Male
CA Finite cell line
//
ID HITA5
AC CVCL_D366
SY Human Internal Thoracic A5
RX PubMed=11557739;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D363 ! HITA1
OI CVCL_D364 ! HITA2
OI CVCL_D365 ! HITA4
OI CVCL_D367 ! HITB2
OI CVCL_D368 ! HITB5
OI CVCL_D369 ! HITC1
OI CVCL_D370 ! HITC6
OI CVCL_D371 ! HITD1
OI CVCL_D372 ! HITD4
OI CVCL_D373 ! HITD5
OI CVCL_D374 ! HITD6
SX Male
CA Finite cell line
//
ID HITB2
AC CVCL_D367
SY Human Internal Thoracic B2
RX PubMed=11557739;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D363 ! HITA1
OI CVCL_D364 ! HITA2
OI CVCL_D365 ! HITA4
OI CVCL_D366 ! HITA5
OI CVCL_D368 ! HITB5
OI CVCL_D369 ! HITC1
OI CVCL_D370 ! HITC6
OI CVCL_D371 ! HITD1
OI CVCL_D372 ! HITD4
OI CVCL_D373 ! HITD5
OI CVCL_D374 ! HITD6
SX Male
CA Finite cell line
//
ID HITB5
AC CVCL_D368
SY Human Internal Thoracic B5
RX PubMed=10455062;
RX PubMed=11557739;
WW https://www.cedarlanelabs.com/Products/Detail/CLU305?lob=Cellutions
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-465.html
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D363 ! HITA1
OI CVCL_D364 ! HITA2
OI CVCL_D365 ! HITA4
OI CVCL_D366 ! HITA5
OI CVCL_D367 ! HITB2
OI CVCL_D369 ! HITC1
OI CVCL_D370 ! HITC6
OI CVCL_D371 ! HITD1
OI CVCL_D372 ! HITD4
OI CVCL_D373 ! HITD5
OI CVCL_D374 ! HITD6
SX Male
CA Finite cell line
//
ID HITC1
AC CVCL_D369
SY Human Internal Thoracic C1
RX PubMed=11557739;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D363 ! HITA1
OI CVCL_D364 ! HITA2
OI CVCL_D365 ! HITA4
OI CVCL_D366 ! HITA5
OI CVCL_D367 ! HITB2
OI CVCL_D368 ! HITB5
OI CVCL_D370 ! HITC6
OI CVCL_D371 ! HITD1
OI CVCL_D372 ! HITD4
OI CVCL_D373 ! HITD5
OI CVCL_D374 ! HITD6
SX Male
CA Finite cell line
//
ID HITC6
AC CVCL_D370
SY Human Internal Thoracic C6
DR BTO; BTO:0004118
RX PubMed=11557739;
WW https://www.cedarlanelabs.com/Products/Detail/CLU306?lob=Cellutions
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D363 ! HITA1
OI CVCL_D364 ! HITA2
OI CVCL_D365 ! HITA4
OI CVCL_D366 ! HITA5
OI CVCL_D367 ! HITB2
OI CVCL_D368 ! HITB5
OI CVCL_D369 ! HITC1
OI CVCL_D371 ! HITD1
OI CVCL_D372 ! HITD4
OI CVCL_D373 ! HITD5
OI CVCL_D374 ! HITD6
SX Male
CA Finite cell line
//
ID HITD1
AC CVCL_D371
SY Human Internal Thoracic D1
RX PubMed=11557739;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D363 ! HITA1
OI CVCL_D364 ! HITA2
OI CVCL_D365 ! HITA4
OI CVCL_D366 ! HITA5
OI CVCL_D367 ! HITB2
OI CVCL_D368 ! HITB5
OI CVCL_D369 ! HITC1
OI CVCL_D370 ! HITC6
OI CVCL_D372 ! HITD4
OI CVCL_D373 ! HITD5
OI CVCL_D374 ! HITD6
SX Male
CA Finite cell line
//
ID HITD4
AC CVCL_D372
SY Human Internal Thoracic D4
RX PubMed=11557739;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D363 ! HITA1
OI CVCL_D364 ! HITA2
OI CVCL_D365 ! HITA4
OI CVCL_D366 ! HITA5
OI CVCL_D367 ! HITB2
OI CVCL_D368 ! HITB5
OI CVCL_D369 ! HITC1
OI CVCL_D370 ! HITC6
OI CVCL_D371 ! HITD1
OI CVCL_D373 ! HITD5
OI CVCL_D374 ! HITD6
SX Male
CA Finite cell line
//
ID HITD5
AC CVCL_D373
SY Human Internal Thoracic D5
RX PubMed=11557739;
WW https://www.cedarlanelabs.com/Products/Detail/CLU307?lob=Cellutions
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D363 ! HITA1
OI CVCL_D364 ! HITA2
OI CVCL_D365 ! HITA4
OI CVCL_D366 ! HITA5
OI CVCL_D367 ! HITB2
OI CVCL_D368 ! HITB5
OI CVCL_D369 ! HITC1
OI CVCL_D370 ! HITC6
OI CVCL_D371 ! HITD1
OI CVCL_D372 ! HITD4
OI CVCL_D374 ! HITD6
SX Male
CA Finite cell line
//
ID HITD6
AC CVCL_D374
SY Human Internal Thoracic D6
RX PubMed=11557739;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D363 ! HITA1
OI CVCL_D364 ! HITA2
OI CVCL_D365 ! HITA4
OI CVCL_D366 ! HITA5
OI CVCL_D367 ! HITB2
OI CVCL_D368 ! HITB5
OI CVCL_D369 ! HITC1
OI CVCL_D370 ! HITC6
OI CVCL_D371 ! HITD1
OI CVCL_D372 ! HITD4
OI CVCL_D373 ! HITD5
SX Male
CA Finite cell line
//
ID HIUML
AC CVCL_W383
RX PubMed=16130900;
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HIVE-101
AC CVCL_6776
SY Human Iliac Vein Endothelial-101; AG10770; AG10770A
DR CLO; CLO_0021516
DR ATCC; CRL-2479
DR Coriell; AG10770
DR Coriell; WC00102
RX PubMed=1309825;
CC Part of: Wistar Institute Special Collection vascular cell lines.
CC Discontinued: ATCC; CRL-2479; true.
CC Discontinued: Coriell; WC00102; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 10,12
ST D7S820: 9,13
ST TH01: 8,9
ST TPOX: 11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3287 ! HIAE-101
SX Female
CA Finite cell line
//
ID HIVE-109
AC CVCL_0E18
SY Human Iliac Vein Endothelial-109; AG10768
DR CLO; CLO_0021514
DR Coriell; AG10768
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0E17 ! HIAE-109
SX Female
CA Finite cell line
//
ID HIVE-24
AC CVCL_0F59
SY Human Iliac Vein Endothelial-24; AG09874; AG10451
DR CLO; CLO_0021939
DR CLO; CLO_0021550
DR Coriell; AG09874
DR Coriell; AG10451
RX PubMed=3654763;
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0F58 ! HIAE-24
SX Female
CA Finite cell line
//
ID HIVE-26
AC CVCL_3292
SY Human Iliac Vein Endothelial-26; WC00110
DR CLO; CLO_0003759
DR ATCC; CRL-2603
DR Coriell; WC00110
CC Part of: Wistar Institute Special Collection vascular cell lines.
CC Discontinued: ATCC; CRL-2603; true.
CC Discontinued: Coriell; WC00110; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 13,14
ST D5S818: 12
ST D7S820: 10
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0E12 ! HAAE-26
OI CVCL_3716 ! HPAE-26
OI CVCL_3718 ! HPVE-26
SX Male
CA Finite cell line
//
ID HIVE-27
AC CVCL_0F02
SY Human Iliac Vein Endothelial-27
DR ATCC; CRL-2600
CC Part of: Wistar Institute Special Collection vascular cell lines.
CC Discontinued: ATCC; CRL-2600; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0E14 ! HAAE-27
OI CVCL_0E13 ! HIAE-27
SX Male
CA Finite cell line
//
ID HIVE-35
AC CVCL_0E24
SY Human Iliac Vein Endothelial-35; AG11182
DR CLO; CLO_0021610
DR Coriell; AG11182
RX PubMed=3654763;
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HIVE-36
AC CVCL_0E25
SY Human Iliac Vein Endothelial-36; AG11184
DR CLO; CLO_0021611
DR Coriell; AG11184
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IV55 ! HIAE-36/7-1
SX Male
CA Finite cell line
//
ID HIVE-38
AC CVCL_6777
SY Human Iliac Vein Endothelial-38; WC00109
DR ATCC; CRL-2601
DR Coriell; WC00109
CC Part of: Wistar Institute Special Collection vascular cell lines.
CC Discontinued: ATCC; CRL-2601; true.
CC Discontinued: Coriell; WC00109; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 12
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 14,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3288 ! HIAE-38
SX Male
CA Finite cell line
//
ID HIVE-43
AC CVCL_0E09
SY Human Iliac Vein Endothelial-43
DR ATCC; CRL-2477
CC Part of: Wistar Institute Special Collection vascular cell lines.
CC Discontinued: ATCC; CRL-2477; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0E15 ! HIAE-43/7-12
SX Male
CA Finite cell line
//
ID HIVE-46
AC CVCL_0E26
SY Human Iliac Vein Endothelial-46; AG11188
DR CLO; CLO_0021612
DR Coriell; AG11188
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HIVE-54/7-2
AC CVCL_IV53
SY Human Iliac Vein Endothelial-54/7-2
RX PubMed=1309825;
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HIVE-55
AC CVCL_3293
SY Human Iliac Vein Endothelial-55; WC00113
DR CLO; CLO_0003760
DR ATCC; CRL-2609
DR Coriell; WC00113
CC Part of: Wistar Institute Special Collection vascular cell lines.
CC Discontinued: ATCC; CRL-2609; true.
CC Discontinued: Coriell; WC00113; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,14
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 10
ST TH01: 7,8
ST TPOX: 8,10
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3289 ! HIAE-55
SX Female
CA Finite cell line
//
ID HIVE-65
AC CVCL_3294
SY Human Iliac Vein Endothelial-65; WC00111
DR CLO; CLO_0003761
DR ATCC; CRL-2605
DR Coriell; WC00111
CC Part of: Wistar Institute Special Collection vascular cell lines.
CC Discontinued: ATCC; CRL-2605; true.
CC Discontinued: Coriell; WC00111; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,14
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 9,12
ST TH01: 6
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3290 ! HIAE-65
SX Female
CA Finite cell line
//
ID HIVE-78
AC CVCL_3295
SY Human Iliac Vein Endothelial-78; WC00101
DR CLO; CLO_0003762
DR ATCC; CRL-2476
DR Coriell; WC00101
CC Part of: Wistar Institute Special Collection vascular cell lines.
CC Discontinued: ATCC; CRL-2476; true.
CC Discontinued: Coriell; WC00101; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3291 ! HIAE-78
SX Female
CA Finite cell line
//
ID HIVE-79/7-2
AC CVCL_IV52
SY Human Iliac Vein Endothelial-79/7-2
RX PubMed=1309825;
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HIVE-81/7-2
AC CVCL_IV54
SY Human Iliac Vein Endothelial-81/7-2
RX PubMed=1309825;
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HIVE-86
AC CVCL_0E19
SY Human Iliac Vein Endothelial-86; AG10773
DR CLO; CLO_0021515
DR Coriell; AG10773
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HIVE-87
AC CVCL_0E20
SY Human Iliac Vein Endothelial-87; AG10774
DR CLO; CLO_0021510
DR Coriell; AG10774
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HIVE-98/7-1
AC CVCL_0E16
SY Human Iliac Vein Endothelial-98/7-1; AG09897
DR CLO; CLO_0021935
DR Coriell; AG09897
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HIVS-121T
AC CVCL_2Q18
SY Human Iliac Vein Smooth muscle-121T; AG11546
DR CLO; CLO_0022603
DR Coriell; AG11546
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HIVS-125
AC CVCL_6399
SY Human Iliac Vein Smooth muscle-125; WC00105
DR CLO; CLO_0003763
DR ATCC; CRL-2482
DR BioSample; SAMN03471593
DR Coriell; WC00105
CC Part of: Wistar Institute Special Collection vascular cell lines.
CC Misspelling: 'NIVS-125' in BioSample SAMN03471593.
CC Discontinued: ATCC; CRL-2482; true.
CC Discontinued: Coriell; WC00105; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 10,11
ST D5S818: 10
ST D7S820: 9,11
ST TH01: 7,10
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HIVS-130T
AC CVCL_0N51
SY Human Iliac Vein Smooth muscle-130T; AG11549
DR CLO; CLO_0022598
DR Coriell; AG11549
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0N50 ! HIAS-130T
SX Male
CA Finite cell line
//
ID HJ1.K
AC CVCL_S171
SY HJ1K
DR ATCC; CRL-6271
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6271; true.
OX NCBI_TaxID=37179; ! Hemitragus jemlahicus
OI CVCL_S172 ! HJ1.Ln
OI CVCL_S173 ! HJ1.Lu
OI CVCL_6400 ! HJ1.Ov
OI CVCL_S174 ! HJ1.Th
SX Female
CA Finite cell line
//
ID HJ1.Ln
AC CVCL_S172
SY HJ1LN
DR ATCC; CRL-6272
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6272; true.
OX NCBI_TaxID=37179; ! Hemitragus jemlahicus
OI CVCL_S171 ! HJ1.K
OI CVCL_S173 ! HJ1.Lu
OI CVCL_6400 ! HJ1.Ov
OI CVCL_S174 ! HJ1.Th
SX Female
CA Finite cell line
//
ID HJ1.Lu
AC CVCL_S173
SY HJ1LU
DR ATCC; CRL-6273
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6273; true.
OX NCBI_TaxID=37179; ! Hemitragus jemlahicus
OI CVCL_S171 ! HJ1.K
OI CVCL_S172 ! HJ1.Ln
OI CVCL_6400 ! HJ1.Ov
OI CVCL_S174 ! HJ1.Th
SX Female
CA Finite cell line
//
ID HJ1.Ov
AC CVCL_6400
DR CLO; CLO_0003764
DR ATCC; CRL-6274
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/hj1ov/hj1ovcells.html
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6274; true.
OX NCBI_TaxID=37179; ! Hemitragus jemlahicus
OI CVCL_S171 ! HJ1.K
OI CVCL_S172 ! HJ1.Ln
OI CVCL_S173 ! HJ1.Lu
OI CVCL_S174 ! HJ1.Th
SX Female
CA Finite cell line
//
ID HJ1.Th
AC CVCL_S174
SY HJ1th
DR ATCC; CRL-6275
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6275; true.
OX NCBI_TaxID=37179; ! Hemitragus jemlahicus
OI CVCL_S171 ! HJ1.K
OI CVCL_S172 ! HJ1.Ln
OI CVCL_S173 ! HJ1.Lu
OI CVCL_6400 ! HJ1.Ov
SX Female
CA Finite cell line
//
ID HJ2.K
AC CVCL_S175
SY HJ2K
DR ATCC; CRL-6276
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6276; true.
OX NCBI_TaxID=37179; ! Hemitragus jemlahicus
OI CVCL_6401 ! HJ2.Lu
OI CVCL_S176 ! HJ2.Sp
OI CVCL_S177 ! HJ2.Tes
SX Male
CA Finite cell line
//
ID HJ2.Lu
AC CVCL_6401
DR CLO; CLO_0003765
DR ATCC; CRL-6277
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6277; true.
OX NCBI_TaxID=37179; ! Hemitragus jemlahicus
OI CVCL_S175 ! HJ2.K
OI CVCL_S176 ! HJ2.Sp
OI CVCL_S177 ! HJ2.Tes
SX Male
CA Finite cell line
//
ID HJ2.Sp
AC CVCL_S176
SY HJ2Sp
DR ATCC; CRL-6278
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6278; true.
OX NCBI_TaxID=37179; ! Hemitragus jemlahicus
OI CVCL_S175 ! HJ2.K
OI CVCL_6401 ! HJ2.Lu
OI CVCL_S177 ! HJ2.Tes
SX Male
CA Finite cell line
//
ID HJ2.Tes
AC CVCL_S177
DR ATCC; CRL-6279
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6279; true.
OX NCBI_TaxID=37179; ! Hemitragus jemlahicus
OI CVCL_S175 ! HJ2.K
OI CVCL_6401 ! HJ2.Lu
OI CVCL_S176 ! HJ2.Sp
SX Male
CA Finite cell line
//
ID HK
AC CVCL_L805
RX PubMed=2827813;
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HK-1
AC CVCL_7047
SY HK1
RX PubMed=1851672;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HK-2 [Human kidney]
AC CVCL_0302
SY Hk-2; HK2; Human Kidney-2
DR BTO; BTO:0003575
DR CLO; CLO_0003771
DR MCCL; MCC:0000193
DR ATCC; CRL-2190
DR BCRC; 60097
DR BioSample; SAMN03472562
DR CCLE; HK2_KIDNEY
DR CCRID; 3111C0001CCC000159
DR CCRID; 3142C0001000000136
DR Cosmic; 2520628
DR GEO; GSM827261
DR KCB; KCB 200815YJ
DR KCLB; 22190
DR Lonza; 769
RX PubMed=8127021;
RX PubMed=20555413;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
ST Source(s): ATCC; KCLB
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 9
ST D16S539: 11,12
ST D3S1358: 16,17
ST D5S818: 12
ST D7S820: 10,11
ST FGA: 20,22
ST TH01: 9
ST TPOX: 8,9
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HK-2 [Human lung carcinoma]
AC CVCL_7048
RX PubMed=1851672;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7047 ! HK-1
SX Male
CA Cancer cell line
//
ID HK-PEG-1
AC CVCL_3441
SY PEG-1-6; PEG 1-6
DR CLO; CLO_0003766
DR CLO; CLO_0003773
DR CLO; CLO_0008417
DR CLDB; cl5247
DR ATCC; CCL-189
DR BCRC; 60188
DR ECACC; 90112229
DR IZSLER; BS Hy 31
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID HKA-1
AC CVCL_2943
DR BioSample; SAMN03472533
DR JCRB; JCRB1017
DR JCRB; NIHS0251
RX CelloPub=CLPUB00048;
CC Doubling time: ~34 hours (CelloPub=CLPUB00048).
CC Discontinued: JCRB; NIHS0251; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10
ST D16S539: 10
ST D5S818: 10
ST D7S820: 7,12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 18
DI NCIt; C3146; Keratoacanthoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HKB-1
AC CVCL_5290
DR BioSample; SAMN03152013
RX PubMed=9722894;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HKB-1
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown not to be from a Hodgkin tumor (PubMed=12592342, PubMed=20143388).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Undefined cell line type
//
ID HKB-11
AC CVCL_3712
SY HKB11; Hybrid of Kidney and B cells-11
DR CLO; CLO_0003772
DR ATCC; CRL-12568
DR BioSample; SAMN03473641
DR Wikidata; Q27555063
RX Patent=US6136599;
RX PubMed=12432229;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11,12
ST D13S317: 12,14
ST D16S539: 9,10
ST D5S818: 8,9,12
ST D7S820: 10,11,12
ST TH01: 7,9,9.3
ST TPOX: 6,11
ST vWA: 15,16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6354 ! 2B8
HI CVCL_A784 ! HEK293S
CA Hybrid cell line
//
ID HKb20
AC CVCL_E065
DR CLO; CLO_0050900
DR BioSample; SAMN03471986
DR RCB; RCB2253
RX PubMed=12403648;
CC Transfected with: UniProtKB; Q9NDN4; B.mori BtR175b.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,13
ST D5S818: 8,9
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HKBML
AC CVCL_8161
DR CLO; CLO_0050638
DR BioSample; SAMN03472185
DR RCB; RCB0820
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 9,13
ST D5S818: 10,11
ST D7S820: 11,12
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 14,17
DI NCIt; C7611; Cerebral lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HKBMM
AC CVCL_8162
DR CLO; CLO_0050633
DR BioSample; SAMN03472212
DR RCB; RCB0680
RX PubMed=16035506;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8,11
ST D16S539: 10
ST D5S818: 11
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HKC-11
AC CVCL_Y911
SY HKC11
RX PubMed=9042817;
CC Transformant: Ad12-SV40.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y909 ! HKC-5
OI CVCL_Y910 ! HKC-8
CA Transformed cell line
//
ID HKC-5
AC CVCL_Y909
SY HKC5
RX PubMed=9042817;
RX PubMed=17158639;
CC Transformant: Ad12-SV40.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y910 ! HKC-8
OI CVCL_Y911 ! HKC-11
CA Transformed cell line
//
ID HKC-8
AC CVCL_Y910
SY HKC8; HKC clone 8
RX PubMed=9042817;
RX PubMed=11007312;
RX PubMed=19937734;
CC Transformant: Ad12-SV40.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y909 ! HKC-5
OI CVCL_Y911 ! HKC-11
CA Transformed cell line
//
ID HKCI-1
AC CVCL_E308
RX PubMed=10958934;
RX PubMed=11793441;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HKCI-2
AC CVCL_M173
RX DOI=10.1385/CP:1:3-4:313;
RX PubMed=11793441;
CC Characteristics: Has lost chromosome Y.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HKCI-3
AC CVCL_M174
RX DOI=10.1385/CP:1:3-4:313;
RX PubMed=11793441;
CC Characteristics: Has lost chromosome Y.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HKCI-4
AC CVCL_M175
RX DOI=10.1385/CP:1:3-4:313;
RX PubMed=11793441;
CC Characteristics: Has lost chromosome Y.
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HKe-3
AC CVCL_9796
SY HKE-3; Hke-3; HKE3; Hke3
DR BTO; BTO:0003469
RX PubMed=8465203;
RX PubMed=9354428;
CC Characteristics: In HCT 116 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 6407; KRAS.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HKESC-1
AC CVCL_D568
SY HKESC1; Hong Kong Esophageal Squamous Carcinoma-1
DR BTO; BTO:0005164
RX PubMed=10748291;
WW http://www.addexbio.com/productdetail?pid=47
CC Characteristics: Has lost chromosome Y.
CC Doubling time: 46 hours (PubMed=10748291).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HKESC-1/cis
AC CVCL_S525
RX PubMed=21177414;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D568 ! HKESC-1
SX Male
CA Cancer cell line
//
ID HKESC-2
AC CVCL_D571
SY HKESC2; Hong Kong Esophageal Squamous Carcinoma-2
DR BTO; BTO:0005165
RX PubMed=12127396;
RX PubMed=15885884;
CC Doubling time: 24 hours (PubMed=12127396).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HKESC-3
AC CVCL_D572
SY HKESC3; Hong Kong Esophageal Squamous Carcinoma-3
DR BTO; BTO:0005166
RX PubMed=12127396;
CC Doubling time: 48 hours (PubMed=12127396).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HKESC-4
AC CVCL_E304
SY HKESC4; Hong Kong Esophageal Squamous Carcinoma-4
RX PubMed=17889704;
CC Doubling time: 63 hours (PubMed=17889704).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HKGZ-CC
AC CVCL_E329
RX CelloPub=CLPUB00275;
RX PubMed=17914572;
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HKh-2
AC CVCL_9797
SY HKH-2; HKH2; Hkh2
RX PubMed=8465203;
RX PubMed=9354428;
CC Characteristics: In HCT 116 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 6407; KRAS.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HKiPS4F
AC CVCL_V198
SY HKiPS-4F; ESi037-A
DR BioSamples; SAMEA4091844
DR hPSCreg; ESi037-A
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/HKiPS4F.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HKMFH
AC CVCL_W460
RX PubMed=2562089;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HKMS
AC CVCL_W524
RX PubMed=2519215;
DI NCIt; C3269; Schwannoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HKMUS
AC CVCL_8776
DR BioSample; SAMN03151914
RX PubMed=1698374;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SKG-II-SF derivative (PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8159 ! SKG-II-SF
SX Female
CA Cancer cell line
//
ID HKMUS-SF
AC CVCL_8230
DR BioSample; SAMN03151915
DR RCB; RCB0686
RX PubMed=16643607;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (HKMUS) has been shown to be a SKG-II-SF derivative (PubMed=16643607, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: RCB; RCB0686; true.
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8776 ! HKMUS
SX Female
CA Cancer cell line
//
ID HKNM-2
AC CVCL_H684
SY HKNM2
CC From: Popper H.; University of Graz; Graz; Austria.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HKRT-II
AC CVCL_M686
RX PubMed=10834109;
CC Derived from metastatic site: Retroperitoneal space.
DI NCIt; C7733; Testicular choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HKT-1097
AC CVCL_2070
DR CLO; CLO_0003774
DR DSMZ; ACC-445
DR ECACC; 98061003
RX PubMed=10476921;
CC Doubling time: ~19 hours (DSMZ); 36 hours (ECACC).
CC Transformant: ChEBI; CHEBI:41922; Diethylstilbestrol.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Male
CA Cancer cell line
//
ID HKT-2
AC CVCL_Y024
RX PubMed=2224863;
DI NCIt; C45544; Lung mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HKT-3
AC CVCL_Y025
RX PubMed=2224863;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HKT-5
AC CVCL_Y026
RX PubMed=2224863;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HKT-6
AC CVCL_Y027
RX PubMed=2224863;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HKT-7
AC CVCL_Y028
RX PubMed=2224863;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HKT-8
AC CVCL_Y029
RX PubMed=2224863;
DI NCIt; C45544; Lung mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HKTN-2
AC CVCL_W669
DR IZSLER; BS CL 167
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID HKULC 1
AC CVCL_A392
SY HKULC1
DR Cosmic; 1053059
RX PubMed=17409975;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HKULC 2
AC CVCL_A393
SY HKULC2
DR Cosmic; 1053060
RX PubMed=17409975;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HKULC 3
AC CVCL_A394
SY HKULC3
DR Cosmic; 1053061
RX PubMed=17409975;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HKULC 4
AC CVCL_A395
SY HKULC4
DR Cosmic; 1053062
RX PubMed=17409975;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HKUS
AC CVCL_X942
RX PubMed=2838556;
RX PubMed=10457904;
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HL
AC CVCL_2492
DR CCRID; 3142C0001000000102
DR ECACC; 96121720
DR ChEMBL-Cells; CHEMBL3307999
DR ChEMBL-Targets; CHEMBL612594
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,10
ST D16S539: 12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 14,19
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HL-1
AC CVCL_0303
SY HL1
DR BTO; BTO:0003264
DR MCCL; MCC:0000194
DR CCRID; 3142C0001000000549
DR Lonza; 740
DR Millipore; SCC065
RX PubMed=9501201;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-549.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID HL-1 Friendly Myeloma-653
AC CVCL_D145
SY HL-1 Friendly Myeloma 653; HL-1 Friendly myeloma; HL-1
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
SX Female
CA Cancer cell line
//
ID HL-2
AC CVCL_N700
SY H-L2
RX PubMed=9053739;
CC Transfected with: HGNC; 1390; CACNA1C.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID HL-60
AC CVCL_0002
SY HL60; HL 60
DR BTO; BTO:0000738
DR CLO; CLO_0003775
DR CLO; CLO_0050972
DR EFO; EFO_0002793
DR MCCL; MCC:0000195
DR CLDB; cl1682
DR CLDB; cl1684
DR CLDB; cl1685
DR CLDB; cl1686
DR CLDB; cl1687
DR CLDB; cl1688
DR CLDB; cl1689
DR CLDB; cl1690
DR CLDB; cl1691
DR CLDB; cl1693
DR ATCC; CCL-240
DR BCRC; 60027
DR BCRJ; 0104
DR BioSample; SAMN01821559
DR BioSample; SAMN01821682
DR BioSample; SAMN03472768
DR BioSample; SAMN03473174
DR CCLE; HL60_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CCRID; 3111C0001CCC000037
DR CCRID; 3131C0001000700023
DR CCRID; 3142C0001000000027
DR CCRID; 3142C0001000000028
DR ChEMBL-Cells; CHEMBL3307411
DR ChEMBL-Cells; CHEMBL3307654
DR ChEMBL-Targets; CHEMBL383
DR ChEMBL-Targets; CHEMBL614583
DR CLS; 300209/p671_HL-60
DR Cosmic; 716179
DR Cosmic; 716190
DR Cosmic; 724817
DR Cosmic; 787433
DR Cosmic; 798224
DR Cosmic; 798665
DR Cosmic; 808506
DR Cosmic; 821043
DR Cosmic; 851996
DR Cosmic; 875866
DR Cosmic; 905938
DR Cosmic; 919116
DR Cosmic; 922161
DR Cosmic; 922683
DR Cosmic; 924049
DR Cosmic; 932769
DR Cosmic; 949099
DR Cosmic; 975252
DR Cosmic; 981578
DR Cosmic; 991557
DR Cosmic; 994170
DR Cosmic; 999724
DR Cosmic; 1012068
DR Cosmic; 1019836
DR Cosmic; 1037661
DR Cosmic; 1070693
DR Cosmic; 1078724
DR Cosmic; 1089519
DR Cosmic; 1092602
DR Cosmic; 1107177
DR Cosmic; 1127250
DR Cosmic; 1130234
DR Cosmic; 1168468
DR Cosmic; 1176580
DR Cosmic; 1181599
DR Cosmic; 1191695
DR Cosmic; 1192826
DR Cosmic; 1226863
DR Cosmic; 1281315
DR Cosmic; 1305337
DR Cosmic; 1308224
DR Cosmic; 1319549
DR Cosmic; 1451845
DR Cosmic; 1465966
DR Cosmic; 1523825
DR Cosmic; 1524830
DR Cosmic; 1582390
DR Cosmic; 1601062
DR Cosmic; 1998444
DR Cosmic; 2036678
DR Cosmic; 2089652
DR Cosmic; 2131539
DR Cosmic; 2301565
DR Cosmic; 2306208
DR Cosmic-CLP; 905938
DR DSMZ; ACC-3
DR ECACC; 98070106
DR ENCODE; ENCBS069ENC
DR ENCODE; ENCBS070ENC
DR ENCODE; ENCBS215JQI
DR ENCODE; ENCBS308XSW
DR ENCODE; ENCBS373UEY
DR ENCODE; ENCBS482VCU
DR ENCODE; ENCBS869DKF
DR GDSC; 905938
DR GEO; GSM50194
DR GEO; GSM50258
DR GEO; GSM213809
DR GEO; GSM236782
DR GEO; GSM236818
DR GEO; GSM472908
DR GEO; GSM472942
DR GEO; GSM482507
DR GEO; GSM545496
DR GEO; GSM545497
DR GEO; GSM750812
DR GEO; GSM799346
DR GEO; GSM799409
DR GEO; GSM887083
DR GEO; GSM888153
DR GEO; GSM945222
DR GEO; GSM945255
DR GEO; GSM1153417
DR GEO; GSM1181331
DR GEO; GSM1181348
DR GEO; GSM1374535
DR GEO; GSM1374536
DR GEO; GSM1669883
DR ICLC; HTL95010
DR IFO; IFO50022
DR IGRhCellID; HL60
DR IZSLER; BS TCL 25
DR JCRB; JCRB0085
DR KCB; KCB 2014051YJ
DR KCLB; 10240
DR Lonza; 64
DR MeSH; D018922
DR NCBI_Iran; C217
DR PRIDE; PXD000589
DR RCB; RCB0041
DR RCB; RCB3683
DR SKY/M-FISH/CGH; 5609
DR TKG; TKG 0345
DR TOKU-E; 1488
DR Wikidata; Q5630035
RX PubMed=271272;
RX PubMed=288488;
RX PubMed=6091813;
RX PubMed=6582512;
RX PubMed=6996765;
RX PubMed=8316623;
RX PubMed=9557624;
RX PubMed=9737686;
RX PubMed=9738977;
RX PubMed=12661003;
RX PubMed=15843827;
RX PubMed=16120335;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=23955599;
RX PubMed=25485619;
RX PubMed=25894527;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://en.wikipedia.org/wiki/HL60
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HL-60
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=32
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/HL-60_Stam_protocol.pdf
WW http://www.proteinatlas.org/learn/cellines
WW http://www.infarktforschung.de/macrophages_cell_lines.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-132.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I.
CC Biotechnology: Used a source of mitochondrial DNA for USA forensic testing.
CC Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC Omics: Cell surface proteome.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: Mitochondrial genome sequenced.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'IIL-60' in ChEMBL CHEMBL614583 and CHEMBL3307411.
ST Source(s): ATCC; CLS; COG; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; PubMed=11416159; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D18S51: 14 (CLS)
ST D18S51: 14,15 (PubMed=11416159; PubMed=25877200)
ST D19S433: 14
ST D21S11: 30 (CLS; PubMed=11416159)
ST D21S11: 29,30 (COG; PubMed=25877200)
ST D2S1338: 17
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 13 (CLS)
ST D8S1179: 12,13 (PubMed=11416159; PubMed=25877200)
ST FGA: 22,24
ST Penta D: 10,12
ST Penta E: 13 (CLS)
ST Penta E: 13,14 (PubMed=25877200)
ST TH01: 7,8 (ATCC; CLS; COG; Cosmic-CLP; DSMZ; KCLB; PubMed=11416159; PubMed=25877200; RCB; TKG)
ST TH01: 8 (ECACC; JCRB)
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HL-60 clone 15
AC CVCL_2493
SY HL-60 clone15; Clone 15 HL-60
DR CLO; CLO_0002499
DR CLDB; cl5151
DR ATCC; CRL-1964
DR BCRC; 60273
DR ECACC; 98052918
RX PubMed=3184985;
ST Source(s): ATCC; ECACC
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL-60/ADR
AC CVCL_0304
SY HL60/ADR; HL60/Adr; HL60-ADR
DR BTO; BTO:0003572
DR MCCL; MCC:0000196
RX PubMed=2425939;
RX PubMed=2573357;
RX PubMed=2886122;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL-60/AMSA
AC CVCL_IP18
RX PubMed=1311390;
RX PubMed=1651812;
RX PubMed=2550442;
CC Characteristics: Has a TOP2A p.Arg487Lys mutation.
CC Selected for resistance to: ChEBI; CHEBI:2687; Amsacrine.
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL-60/ara-C [Japan 2011]
AC CVCL_4V19
RX PubMed=21290089;
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL-60/ara-C [USA 1984]
AC CVCL_Z938
RX PubMed=6091869;
CC Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL-60/DNR
AC CVCL_4458
SY HL60/DNR; HL60-DNR
DR BTO; BTO:0003573
RX PubMed=9557624;
CC Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL-60/MX1
AC CVCL_3332
SY HL 60/MX1; HL-60/MX-1; HL60/MX1
DR CLO; CLO_0003781
DR ATCC; CRL-2258
DR BioSample; SAMN03471850
DR IGRhCellID; HL60MX1
DR NCBI_Iran; C553
RX PubMed=2568172;
CC Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL-60/MX2
AC CVCL_3333
SY HL-60/MX-2; HL60/MX2
DR BTO; BTO:0003571
DR CLO; CLO_0003782
DR ATCC; CRL-2257
RX PubMed=2568172;
CC Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3332 ! HL-60/MX1
SX Female
CA Cancer cell line
//
ID HL-60/R3
AC CVCL_II78
RX PubMed=1737356;
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL-60/S4
AC CVCL_II77
DR ATCC; CRL-3306
RX PubMed=1737356;
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL-60/VCR
AC CVCL_0305
SY HL60/VCR
DR MCCL; MCC:0000197
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL-60/Vinc
AC CVCL_4967
SY HL60/Vinc
DR BTO; BTO:0002591
RX PubMed=2886122;
RX PubMed=2573357;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL-60-R2
AC CVCL_4635
DR CLO; CLO_0051006
DR RCB; RCB1550
CC Selected for resistance to: ChEBI; CHEBI:27300; Vitamin D.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL-60(TB)
AC CVCL_A794
SY HL-60 (TB); HL-60-TB; HL-60TB; HL-60 TB
DR BTO; BTO:0004119
DR Cosmic; 974252
DR Cosmic; 1175855
DR Cosmic; 1312323
DR SKY/M-FISH/CGH; 2738
RX PubMed=2041050;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=27807467;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 28.6 hours (DTP).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
ST Source(s): PubMed=19372543
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D18S51: 14,15
ST D19S433: 14
ST D21S11: 29,30
ST D2S1338: 17
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 12,13
ST FGA: 22
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HL/CAFdA20
AC CVCL_4V55
RX PubMed=23421409;
CC Selected for resistance to: ChEBI; CHEBI:681569; Clofarabine (CAFdA).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL/CAFdA80
AC CVCL_4V56
RX PubMed=23421409;
CC Selected for resistance to: ChEBI; CHEBI:681569; Clofarabine (CAFdA).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4V55 ! HL/CAFdA20
SX Female
CA Cancer cell line
//
ID HL111783
AC CVCL_8231
SY HL-111783
DR BioSample; SAMN03151709
DR RCB; RCB0111
RX PubMed=16643607;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=16643607, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: RCB; RCB0111; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HL165
AC CVCL_X144
RX PubMed=6386741;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HL1C
AC CVCL_D052
DR BTO; BTO:0003565
RX PubMed=2172798;
CC Breed/subspecies: AxC.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0284 ! H4-II-E
SX Male
CA Cancer cell line
//
ID HL2/3
AC CVCL_X685
DR NIH-ARP; 1294-83
RX PubMed=2078409;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HL3T1
AC CVCL_8232
DR NIH-ARP; 1115-122
DR TOKU-E; 4003
RX PubMed=3422113;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HL407
AC CVCL_M510
SY HL 407
RX PubMed=1518305;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HL461
AC CVCL_M511
SY UCD-HL461
RX PubMed=1700238;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HL60 15-12
AC CVCL_2494
DR CLO; CLO_0003776
DR CLDB; cl1694
DR ECACC; 88120805
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL60 Ast.1
AC CVCL_AR88
SY HL60 Ast1
RX PubMed=6641827;
CC Transformant: NCIt; C129638; Astatine-211 alpha radiation.
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL60 Ast.25
AC CVCL_AR85
SY HL60 Ast25
RX PubMed=6641827;
CC Transformant: NCIt; C129638; Astatine-211 alpha radiation.
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL60 Ast.3
AC CVCL_2495
SY HL60 Ast3
DR CLO; CLO_0003777
DR CLDB; cl1695
DR ECACC; 88120801
RX PubMed=6641827;
CC Transformant: NCIt; C129638; Astatine-211 alpha radiation.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 14
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL60 Ast.4
AC CVCL_2496
SY HL60 Ast 4
DR CLO; CLO_0003778
DR CLDB; cl1696
DR ECACC; 88120802
RX PubMed=6641827;
CC Transformant: NCIt; C129638; Astatine-211 alpha radiation.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL60 M2
AC CVCL_2497
SY HL60 m2; HL60m2
DR CLO; CLO_0003779
DR CLDB; cl1697
DR ECACC; 88120803
RX PubMed=6641827;
RX PubMed=6958930;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL60 M4
AC CVCL_2498
SY HL60 m4; HL60m4
DR CLO; CLO_0003780
DR CLDB; cl1698
DR ECACC; 88120804
RX PubMed=6641827;
RX PubMed=6958930;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL60 Sp1
AC CVCL_AR89
SY HL60Sp1
RX PubMed=6641827;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL60(S)
AC CVCL_2944
DR JCRB; JCRB0163
DR JCRB; NIHS0248
CC Discontinued: JCRB; NIHS0248; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HL60RG
AC CVCL_2945
SY HL60-RG
DR GEO; GSM254145
DR JCRB; JCRB0006
RX PubMed=9290701;
ST Source(s): JCRB; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D18S51: 14,15
ST D21S11: 30
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 12,13
ST FGA: 21,22,24
ST TH01: 8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HLaC-78
AC CVCL_6647
SY HLaC 78; HLac 78; HLAC78; HLaC'78; HLa-C-78
DR BTO; BTO:0004020
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=548013;
RX PubMed=3138611;
RX PubMed=6837290;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HLaC-79
AC CVCL_6648
SY HLaC 79; HLac 79; HLAC79; HLaC'79; HlaC79
DR BTO; BTO:0004021
DR Cosmic; 932294
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3138611;
RX PubMed=6837290;
RX PubMed=7543833;
RX PubMed=8679156;
RX PubMed=20947470;
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HLaC-82
AC CVCL_6649
SY HLaC 82; HLac 82; HLAC82; HLaC'82
RX PubMed=7543833;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HLC-1
AC CVCL_5529
SY HLC1
DR CLO; CLO_0050024
DR BioSample; SAMN03472335
DR CCLE; HLC1_LUNG
DR Cosmic; 1154601
DR GEO; GSM784262
DR RCB; RCB0083
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 7,12
ST D13S317: 8
ST D16S539: 9,12
ST D5S818: 9,10
ST D7S820: 11,13
ST TH01: 7,9
ST TPOX: 12
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HLC-1-Luc
AC CVCL_4Y14
DR JCRB; NIHS0711
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5529 ! HLC-1
SX Sex undetermined
CA Cancer cell line
//
ID HLCD4-CAT
AC CVCL_X686
DR NIH-ARP; 1299-127
RX PubMed=2078409;
CC Transfected with: UniProtKB; P62577; E.coli cat.
CC Transfected with: HGNC; 1678; CD4.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S495 ! HeLa-T4+
SX Female
CA Cancer cell line
//
ID HLCL-1
AC CVCL_2946
DR BioSample; SAMN03472809
DR JCRB; JCRB0041
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 8,12
ST TH01: 9
ST TPOX: 9,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HLCZ01
AC CVCL_1J92
RX Patent=US20150204855;
RX PubMed=24616513;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C201309.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HLE
AC CVCL_1281
DR BTO; BTO:0005987
DR BioSample; SAMN03473204
DR CCLE; HLE_LIVER
DR CGH-DB; 9075-4
DR ChEMBL-Cells; CHEMBL3308108
DR ChEMBL-Targets; CHEMBL1075464
DR Cosmic; 907057
DR Cosmic; 945156
DR Cosmic; 1518230
DR Cosmic; 2023859
DR Cosmic; 2162526
DR Cosmic-CLP; 907057
DR GDSC; 907057
DR GEO; GSM827170
DR GEO; GSM887084
DR GEO; GSM888154
DR GEO; GSM936757
DR GEO; GSM1374537
DR GEO; GSM1669884
DR JCRB; JCRB0404
DR TOKU-E; 3605
RX PubMed=52570;
RX PubMed=1778766;
RX PubMed=9290701;
RX PubMed=12029633;
RX PubMed=12679910;
RX PubMed=15767549;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR45 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 9,11
ST D18S51: 15
ST D21S11: 31.2,32.2
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 12,14
ST FGA: 21,24
ST Penta D: 9
ST Penta E: 21
ST TH01: 6,9
ST TPOX: 8
ST vWA: 16
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2947 ! HLF
SX Male
CA Cancer cell line
//
ID HLE/2E1
AC CVCL_X149
RX PubMed=11212141;
CC Transfected with: HGNC; 2631; CYP2E1.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1281 ! HLE
SX Male
CA Cancer cell line
//
ID HLF
AC CVCL_2947
DR CCLE; HLF_LIVER
DR CGH-DB; 9076-4
DR Cosmic; 945157
DR Cosmic; 1187332
DR Cosmic; 1518229
DR Cosmic; 2023860
DR Cosmic; 2162527
DR GEO; GSM887086
DR GEO; GSM888156
DR GEO; GSM936758
DR GEO; GSM1374538
DR GEO; GSM1669885
DR JCRB; JCRB0405
DR LINCS; 50015
RX PubMed=52570;
RX PubMed=1778766;
RX PubMed=9290701;
RX PubMed=12029633;
RX PubMed=15767549;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
RX PubMed=25984343;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR45 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 27 hours (PubMed=25984343).
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 16
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1281 ! HLE
SX Male
CA Cancer cell line
//
ID HLF-a
AC CVCL_2255
SY HLFA
DR CLO; CLO_0003783
DR CLDB; cl1699
DR ATCC; CCL-199
DR BioSample; SAMN03471463
DR CCLE; HLFA_LUNG
DR CCRID; 3111C0002000000055
DR ECACC; 90112703
DR GEO; GSM206505
DR GEO; GSM887085
DR GEO; GSM888155
RX PubMed=7065527;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ECACC; 90112703; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 8,12
ST D7S820: 9,12
ST TH01: 6,9.3
ST TPOX: 6,8
ST vWA: 15
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HLF-R10
AC CVCL_M180
RX PubMed=22179686;
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2947 ! HLF
SX Male
CA Cancer cell line
//
ID HLF-R4
AC CVCL_M181
RX PubMed=22179686;
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2947 ! HLF
SX Male
CA Cancer cell line
//
ID HLfB
AC CVCL_X688
DR NIH-ARP; 1300-84
RX PubMed=2186373;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HLM1
AC CVCL_X699
DR NIH-ARP; 2090-105
RX PubMed=1981148;
CC Transfected with: HGNC; 1678; CD4.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S495 ! HeLa-T4+
SX Female
CA Cancer cell line
//
ID HLM107
AC CVCL_X700
DR NIH-ARP; 2092-88
RX PubMed=1981148;
CC Transfected with: HGNC; 1678; CD4.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S495 ! HeLa-T4+
SX Female
CA Cancer cell line
//
ID HLM30
AC CVCL_X701
DR NIH-ARP; 2091-87
RX PubMed=1981148;
CC Transfected with: HGNC; 1678; CD4.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S495 ! HeLa-T4+
SX Female
CA Cancer cell line
//
ID HLN-STL-C
AC CVCL_X751
SY STL-C
RX PubMed=2551312;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HLSC
AC CVCL_AS77
SY Human Lung Stem Cell line
DR Ximbio; 152715
RX PubMed=22828869;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID HLSC PGK-EGFP
AC CVCL_AS80
DR Ximbio; 152718
RX PubMed=22828869;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AS77 ! HLSC
CA Adult stem cell
//
ID HLSC SH2
AC CVCL_AS79
DR Ximbio; 152717
RX PubMed=22828869;
CC Knockout cell: Method=shRNA knockdown; HGNC; 6876; MAPK14.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AS77 ! HLSC
CA Adult stem cell
//
ID HLSC SH3
AC CVCL_AS78
DR Ximbio; 152716
RX PubMed=22828869;
CC Knockout cell: Method=shRNA knockdown; HGNC; 6876; MAPK14.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AS77 ! HLSC
CA Adult stem cell
//
ID HLtat
AC CVCL_8164
DR CLO; CLO_0050935
DR NIH-ARP; 1293-82
DR RCB; RCB2358
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HLY-1
AC CVCL_H207
SY HLY1
DR Cosmic; 1486589
DR GEO; GSM1374539
RX PubMed=18077790;
CC From: Al Saati T.; Purpan Hospital; Toulouse; France.
CC Omics: Transcriptome analysis.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HLY-1 eIF4E1
AC CVCL_IN94
DR GEO; GSM1511349
DR GEO; GSM1511350
DR GEO; GSM1511351
DR GEO; GSM1511361
DR GEO; GSM1511362
DR GEO; GSM1511363
RX PubMed=25403230;
CC Transfected with: HGNC; 3287; EIF4E.
CC Omics: Transcriptome analysis.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H207 ! HLY-1
CA Cancer cell line
//
ID HLY-1 eIF4E3
AC CVCL_IN95
DR GEO; GSM1511352
DR GEO; GSM1511353
DR GEO; GSM1511354
DR GEO; GSM1511364
DR GEO; GSM1511365
DR GEO; GSM1511366
RX PubMed=25403230;
CC Transfected with: HGNC; 31837; EIF4E3.
CC Omics: Transcriptome analysis.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H207 ! HLY-1
CA Cancer cell line
//
ID HM
AC CVCL_M679
RX PubMed=6190712;
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HM 1
AC CVCL_L696
SY HM1
DR ATCC; HB-8586
RX Patent=US4665032;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L699 ! KE 37.3.2
CA Hybridoma
//
ID HM 162
AC CVCL_W442
SY HM162
RX DOI=10.5794/jjoms.37.1797;
RX PubMed=1882124;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HM 2
AC CVCL_3713
SY HM2
DR CLO; CLO_0003784
DR ATCC; HB-8587
RX Patent=US4665032;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L699 ! KE 37.3.2
CA Hybridoma
//
ID HM-1 [Hamster macrophage]
AC CVCL_2948
SY Hamster Macrophage-1
DR JCRB; JCRB1208
RX PubMed=657122;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Spontaneously immortalized cell line
//
ID HM-1 [Pig/mouse heteromyeloma]
AC CVCL_9V22
RX PubMed=2264287;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_4032 ! P3X63Ag8.653
CA Hybrid cell line
//
ID HM-1 ES
AC CVCL_C315
SY HM-1
DR BTO; BTO:0002896
RX PubMed=1440055;
RX PubMed=1641353;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-543.html
CC Breed/subspecies: 129P2/OlaHsd-Hprt<b-m3>.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID HM-2 [Hamster macrophage]
AC CVCL_W885
SY Hamster Macrophage-2
RX PubMed=657122;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Spontaneously immortalized cell line
//
ID HM-2 [Pig/mouse/bovine heteromyeloma]
AC CVCL_9V23
RX PubMed=2264287;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_9V27 ! 7E2
CA Hybrid cell line
//
ID HM-3
AC CVCL_9V24
RX PubMed=2264287;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_9V23 ! HM-2 [Pig/mouse/bovine heteromyeloma]
CA Hybrid cell line
//
ID HM-4
AC CVCL_9V25
RX PubMed=2264287;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_9V24 ! HM-3
CA Hybrid cell line
//
ID HM-5 [Human/mouse heteromyeloma]
AC CVCL_9V73
RX PubMed=2408619;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybrid cell line
//
ID HM-5 [Pig/mouse/bovine heteromyeloma]
AC CVCL_9V26
RX PubMed=2264287;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_9V24 ! HM-3
CA Hybrid cell line
//
ID HM1-SV40
AC CVCL_6258
RX PubMed=14767565;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HM1-SV40
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HM2-SV40
AC CVCL_6259
RX PubMed=14767565;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HM2-SV40
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HM3KO
AC CVCL_5620
RX PubMed=12839565;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HMA-1
AC CVCL_M378
RX PubMed=1750037;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HMB-2
AC CVCL_6646
SY HMB2
DR BTO; BTO:0001667
DR Cosmic; 1132586
RX PubMed=3065655;
RX PubMed=6819484;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HMB2-5
AC CVCL_S514
SY HMB2-MIA5
RX PubMed=15208686;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6646 ! HMB-2
SX Female
CA Cancer cell line
//
ID HMB2-8
AC CVCL_S515
SY HMB2-MIA8
RX PubMed=15208686;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6646 ! HMB-2
SX Female
CA Cancer cell line
//
ID HMB2-LacZ
AC CVCL_S516
SY HMB2 LacZ; HMB2lacZ
RX PubMed=15208686;
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6646 ! HMB-2
SX Female
CA Cancer cell line
//
ID hMC
AC CVCL_9Q61
RX PubMed=25380573;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID HMC-1
AC CVCL_0003
SY HMC1
DR BTO; BTO:0001669
DR MCCL; MCC:0000199
DR BioSample; SAMN03473342
DR Cosmic; 821806
DR Cosmic; 821913
DR Cosmic; 822147
DR Cosmic; 1122161
DR DSMZ; ACC-283
DR Lonza; 502
DR TOKU-E; 3534
RX PubMed=3131594;
RX PubMed=8191224;
WW http://www.proteinatlas.org/learn/cellines
CC Omics: Deep antibody staining analysis.
CC Omics: Deep RNAseq analysis.
CC Discontinued: DSMZ; ACC-283; true.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 10,11
ST D16S539: 10,12
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C3169; Mast cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HMC-1 5C6
AC CVCL_4T80
SY 5C6
RX PubMed=8950460;
DI NCIt; C3169; Mast cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0003 ! HMC-1
SX Male
CA Cancer cell line
//
ID HMC-1-8
AC CVCL_2949
DR BioSample; SAMN03470817
DR CCLE; HMC18_BREAST
DR JCRB; JCRB0166
RX PubMed=3488124;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 7,12
ST D13S317: 8,10
ST D16S539: 9,12
ST D5S818: 9,10
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 8,12
ST vWA: 16,17
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HMC-1.1
AC CVCL_H206
SY HMC-1_1; HMC1.1; HMC-1(560); HMC-1-560
DR Cosmic; 819947
DR Cosmic; 1476309
DR Cosmic; 1476421
DR Cosmic; 1498491
DR Millipore; SCC067
RX PubMed=11861291;
RX PubMed=12519307;
CC Discontinued: Millipore; SCC067; true.
DI NCIt; C3169; Mast cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0003 ! HMC-1
SX Male
CA Cancer cell line
//
ID HMC-1.2
AC CVCL_H205
SY HMC-1_2; HMC1_2; HMC1.2; HMC-1(560,816); HMC-1-560_816
DR Cosmic; 819945
DR Cosmic; 1476310
DR Cosmic; 1476422
DR Cosmic; 1498492
DR Millipore; SCC062
RX PubMed=11861291;
RX PubMed=12519307;
DI NCIt; C3169; Mast cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0003 ! HMC-1
SX Male
CA Cancer cell line
//
ID HMC3
AC CVCL_II76
SY Human Microglia Clone 3; HMC3 clone 3
DR ATCC; CRL-3304
RX PubMed=7478261;
RX PubMed=20375612;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 9,11
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HMCa
AC CVCL_B402
RX PubMed=2891216;
DI NCIt; C3879; Thyroid gland medullary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HMCB
AC CVCL_3317
SY Human Melanoma Cell Bowes; Bowes melanoma cells
DR BTO; BTO:0001998
DR CLO; CLO_0003785
DR EFO; EFO_0002195
DR ATCC; CRL-9607
DR CCLE; HMCB_SKIN
DR ChEMBL-Cells; CHEMBL3308385
DR ChEMBL-Targets; CHEMBL614824
DR Cosmic; 724822
DR GEO; GSM827473
DR GEO; GSM887087
DR GEO; GSM888157
DR IGRhCellID; HMCB
DR NCBI_Iran; C524
RX Patent=US5010002;
RX PubMed=1970678;
RX PubMed=22460905;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-379.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-109.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Anecdotal: The Bowes cell line is famous for its use in the identification and purification of tissue-type plasminogen activator (tPA).
CC Caution: The exact relationship between HMCB (CVCL_3317) and RPMI-7262/7272/7932/7962/7972 is not clear: all are derived from patient 'Bowes' melanoma.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,11
ST D16S539: 13
ST D5S818: 11,12
ST D7S820: 11,13
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T313 ! RPMI-7262
OI CVCL_T314 ! RPMI-7272
OI CVCL_T315 ! RPMI-7551
OI CVCL_T316 ! RPMI-7781
OI CVCL_T317 ! RPMI-7801
OI CVCL_T318 ! RPMI-7922
OI CVCL_2713 ! RPMI-7932
OI CVCL_T319 ! RPMI-7962
OI CVCL_T320 ! RPMI-7972
OI CVCL_T321 ! RPMI-8002
OI CVCL_T322 ! RPMI-8072
SX Female
CA Cancer cell line
//
ID HMCL-7304
AC CVCL_T053
RX PubMed=23905709;
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID HMEC-1
AC CVCL_0307
SY Hmec-1; HMEC1; CDC/EU.HMEC-1; Human Microvascular Endothelial Cell line-1
DR BTO; BTO:0002828
DR EFO; EFO_0005383
DR MCCL; MCC:0000200
DR ATCC; CRL-3243
DR Lonza; 736
RX PubMed=1361507;
RX PubMed=12453433;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-159.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 8,10
ST TH01: 7
ST TPOX: 8,11
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HMEEC-1
AC CVCL_0E44
SY HEI-HMEEC-1; HEI-HMEEC
DR ATCC; CRL-13012
DR BioSample; SAMN03471351
RX PubMed=12090706;
CC Discontinued: ATCC; CRL-13012; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 10,11
ST D16S539: 12,13
ST D5S818: 10,13
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 9,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID hmel1
AC CVCL_D722
DR Cosmic; 1676366
DR Cosmic; 2051675
RX PubMed=21880213;
RX PubMed=23489693;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID hmel11
AC CVCL_M576
DR Cosmic; 2051677
RX PubMed=23489693;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID hmel9
AC CVCL_D723
DR Cosmic; 1676367
DR Cosmic; 2051676
RX PubMed=21880213;
RX PubMed=23489693;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HMF3A
AC CVCL_4U96
RX PubMed=11209060;
RX PubMed=15574883;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4U97 ! HMF3B
OI CVCL_4U98 ! HMF3C
OI CVCL_4U99 ! HMF3D
OI CVCL_4V00 ! HMF3Dwt
SX Female
CA Conditionally immortalized cell line
//
ID HMF3B
AC CVCL_4U97
RX PubMed=11209060;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4U96 ! HMF3A
OI CVCL_4U98 ! HMF3C
OI CVCL_4U99 ! HMF3D
OI CVCL_4V00 ! HMF3Dwt
SX Female
CA Conditionally immortalized cell line
//
ID HMF3C
AC CVCL_4U98
RX PubMed=11209060;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4U96 ! HMF3A
OI CVCL_4U97 ! HMF3B
OI CVCL_4U99 ! HMF3D
OI CVCL_4V00 ! HMF3Dwt
SX Female
CA Conditionally immortalized cell line
//
ID HMF3D
AC CVCL_4U99
RX PubMed=11209060;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4U96 ! HMF3A
OI CVCL_4U97 ! HMF3B
OI CVCL_4U98 ! HMF3C
OI CVCL_4V00 ! HMF3Dwt
SX Female
CA Conditionally immortalized cell line
//
ID HMF3Dwt
AC CVCL_4V00
RX PubMed=15574883;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4U96 ! HMF3A
OI CVCL_4U97 ! HMF3B
OI CVCL_4U98 ! HMF3C
OI CVCL_4U99 ! HMF3D
SX Female
CA Conditionally immortalized cell line
//
ID HMG
AC CVCL_W288
RX PubMed=6807872;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5915; Oral cavity mucosal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HMKOA
AC CVCL_X938
DR CGH-DB; 345-2
DR CGH-DB; 9350-4
RX CelloPub=CLPUB00154;
RX PubMed=11330945;
RX PubMed=12417041;
RX PubMed=17671176;
DI NCIt; C4026; Ovarian mucinous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HML-Gb3
AC CVCL_U968
DR BTO; BTO:0004898
RX PubMed=19674101;
CC Transfected with: HGNC; 18149; A4GALT.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HMMME
AC CVCL_8163
DR CLO; CLO_0050866
DR BioSample; SAMN03472184
DR Cosmic; 1481547
DR RCB; RCB0819
RX PubMed=15147043;
RX PubMed=18667024;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 8
ST D16S539: 9
ST D5S818: 9
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 14,16
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W379 ! HMMMF
SX Male
CA Cancer cell line
//
ID HMMMF
AC CVCL_W379
RX PubMed=18667024;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8163 ! HMMME
SX Male
CA Cancer cell line
//
ID HMN-1
AC CVCL_U508
SY HMN 1; HMN1; Hybrid Motor Neuron-1; MN1; 2F1.10.14
DR EFO; EFO_0007601
DR ENCODE; ENCBS389RBU
DR ENCODE; ENCBS861BIB
DR ENCODE; ENCBS258GWZ
DR ENCODE; ENCBS880XXF
RX PubMed=1751804;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-184.html
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2132 ! N18TG2
CA Hybrid cell line
//
ID HMO6
AC CVCL_5G94
SY HM06.A1
DR GEO; GSE28642
RX Patent=US6780641;
RX PubMed=11741401;
RX PubMed=15957187;
RX PubMed=22651808;
WW https://www.researchgate.net/post/Human_Microglia_Cell_Line
CC Doubling time: 34.5 hours (PubMed=11741401).
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transformant: v-Myc.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HMOA
AC CVCL_A610
DR CGH-DB; 380-2
DR CGH-DB; 9348-4
DR Cosmic; 877483
DR Cosmic; 1152563
RX PubMed=3732924;
RX PubMed=11330945;
RX PubMed=12417041;
RX PubMed=17671176;
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HMOS-A
AC CVCL_6E82
SY Human Multicentric OsteoSarcoma-Anterior lesion
RX DOI=10.11418/jtca.27.161;
RX PubMed=20440512;
DI NCIt; C6470; Multifocal osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6E83 ! HMOS-P
SX Female
CA Cancer cell line
//
ID HMOS-P
AC CVCL_6E83
SY Human Multicentric OsteoSarcoma-Posterior lesion
RX DOI=10.11418/jtca.27.161;
RX PubMed=20440512;
DI NCIt; C6470; Multifocal osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6E82 ! HMOS-A
SX Female
CA Cancer cell line
//
ID HMPOS
AC CVCL_L355
SY Highly Metastasizing POS cells
DR BTO; BTO:0005369
DR GEO; GSM1974790
RX PubMed=10342286;
RX PubMed=21801068;
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Transcriptome analysis.
CC Breed/subspecies: Mixed breed.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_L413 ! POS [Dog osteosarcoma]
SX Male
CA Cancer cell line
//
ID hMSC-AT
AC CVCL_Y509
DR ENCODE; ENCBS457ENC
DR ENCODE; ENCBS458ENC
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/hMSCAT0102604.12_Gingeras_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID HMSC.AD-100
AC CVCL_1D52
DR CLS; 300641/p853_HMSCAD-100
WW http://www.celleng-tech.com/#!adipose-mesenchymal-stem-cells/cbn7
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID HMSC.AD-500
AC CVCL_1D53
DR CLS; 300645/p833_HMSCAD-500
WW http://www.celleng-tech.com/#!adipose-mesenchymal-stem-cells/cbn7
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID HMSC.AM-100
AC CVCL_1D54
WW http://www.celleng-tech.com/#!amniotic-mesenchymal-stem-cells/cgtj
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID HMSC.AM-500
AC CVCL_1D55
WW http://www.celleng-tech.com/#!amniotic-mesenchymal-stem-cells/cgtj
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID HMSC.BM-100
AC CVCL_1D56
DR CLS; 300661/p857_HMSCBM-100
WW http://www.celleng-tech.com/#!bone-marrow-mesenchymal-stem-cells/c1fzp
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID HMSC.BM-500
AC CVCL_1D57
DR CLS; 300665/p858_HMSCBM-500
WW http://www.celleng-tech.com/#!bone-marrow-mesenchymal-stem-cells/c1fzp
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID HMSC.WJ-100
AC CVCL_1D58
WW http://www.celleng-tech.com/#!whartons-jelly-mesenchymal-stem-cells/c1ilh
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID HMSC.WJ-500
AC CVCL_1D59
DR CLS; 300685/p851_HMSCWJ-500
WW http://www.celleng-tech.com/#!whartons-jelly-mesenchymal-stem-cells/c1ilh
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID hMSC-BM
AC CVCL_Y510
DR ENCODE; ENCBS459ENC
DR ENCODE; ENCBS460ENC
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/hMSCBM0050602.11_Gingeras_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID hMSC-TERT
AC CVCL_Z015
RX PubMed=12042863;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID hMSC-TERT2
AC CVCL_Z016
RX PubMed=15596132;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Z015 ! hMSC-TERT
SX Male
CA Telomerase immortalized cell line
//
ID hMSC-TERT20
AC CVCL_Z018
RX PubMed=15596132;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Z015 ! hMSC-TERT
SX Male
CA Telomerase immortalized cell line
//
ID hMSC-TERT4
AC CVCL_Z017
RX PubMed=15596132;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Z015 ! hMSC-TERT
SX Male
CA Telomerase immortalized cell line
//
ID hMSC-UC
AC CVCL_Y483
DR ENCODE; ENCBS461ENC
DR ENCODE; ENCBS462ENC
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/hMSCUC0081101.7_Gingeras_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID HMSc1
AC CVCL_AX71
RX PubMed=22136931;
CC Group: Haploid karyotype cell line.
CC Breed/subspecies: C57BL/6 x 129.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID HMSc2
AC CVCL_AX72
RX PubMed=22136931;
CC Group: Haploid karyotype cell line.
CC Breed/subspecies: C57BL/6 x 129.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID HMT-3522
AC CVCL_6855
SY HMT3522
DR BTO; BTO:0003884
RX PubMed=3558253;
RX PubMed=7828152;
CC Characteristics: Derived from a nontumorigenic fibrocystic breast lesion.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Spontaneously immortalized cell line
//
ID HMT-3522 S1
AC CVCL_2499
SY HMT-3522-S1; HMT3522S1; S1; S-1; HMT-3522/wt
DR EFO; EFO_0001191
DR Cosmic; 889085
DR ECACC; 98102210
DR LINCS; 51119
DR PRIDE; PXD000309
RX PubMed=22414580;
CC Omics: Deep proteome analysis.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6855 ! HMT-3522
SX Female
CA Cancer cell line
//
ID HMT-3522 S2
AC CVCL_2500
SY HMT-3522-S2; HMT3522S2; S2; S-2
DR ECACC; 98102211
DR Cosmic; 889086
DR Cosmic; 1066170
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 9,11
ST D7S820: 9
ST TH01: 9,9.3
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2499 ! HMT-3522 S1
SX Female
CA Cancer cell line
//
ID HMT-3522 T4-2
AC CVCL_2501
SY HMT-3522/mt-1; mt-1; T4-2; T4
DR ECACC; 98102212
DR LINCS; 51123
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 9,11
ST D7S820: 8,9
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2500 ! HMT-3522 S2
SX Female
CA Cancer cell line
//
ID HMT-3909
AC CVCL_6858
SY HMT3909
RX PubMed=2153455;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HMT-3909S1
AC CVCL_6856
SY HMT-3909 subline S1
RX PubMed=2153455;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6858 ! HMT-3909
SX Female
CA Cancer cell line
//
ID HMT-3909S8
AC CVCL_6857
SY HMT-3909 subline S8
RX PubMed=2153455;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6858 ! HMT-3909
SX Female
CA Cancer cell line
//
ID HMV-I
AC CVCL_8233
SY HMV-1
DR BioSample; SAMN03151710
DR CGH-DB; 9288-4
DR ChEMBL-Cells; CHEMBL3308666
DR ChEMBL-Targets; CHEMBL614825
DR Cosmic; 874382
DR Cosmic; 905202
DR Cosmic; 1007154
DR RCB; RCB0004
DR TKG; TKG 0302
RX PubMed=10508494;
RX PubMed=15467732;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494, PubMed=20143388). Originally thought to originate from a melanoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: RCB; RCB0004; true.
ST Source(s): PubMed=11416159; TKG
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 13.3
ST D16S539: 9
ST D18S51: 16
ST D21S11: 27,28
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 12
ST FGA: 18,21
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18,19
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HMV-II
AC CVCL_1282
SY HMV-2; HMVII
DR BTO; BTO:0002918
DR CLO; CLO_0003786
DR CLO; CLO_0050086
DR CLDB; cl1700
DR BCRJ; 0316
DR BioSample; SAMN03472908
DR CGH-DB; 9289-4
DR ChEMBL-Cells; CHEMBL3308667
DR ChEMBL-Targets; CHEMBL614826
DR Cosmic; 688044
DR Cosmic; 874383
DR Cosmic; 905203
DR Cosmic; 907058
DR Cosmic; 1007155
DR Cosmic; 1477417
DR Cosmic; 2230117
DR Cosmic-CLP; 907058
DR ECACC; 92042701
DR GDSC; 907058
DR GEO; GSM827367
DR GEO; GSM1669886
DR RCB; RCB0777
DR TKG; TKG 0318
RX PubMed=2166075;
RX PubMed=15467732;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 11
ST D18S51: 15
ST D21S11: 29
ST D3S1358: 14,15
ST D5S818: 12
ST D7S820: 8,14
ST D8S1179: 10
ST FGA: 23
ST Penta D: 11
ST Penta E: 5,21
ST TH01: 6,9
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HMVC
AC CVCL_S803
RX PubMed=12889856;
CC Doubling time: 28-32 hours (PubMed=12889856).
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HMY-1
AC CVCL_2950
DR EFO; EFO_0006582
DR BioSample; SAMN03472869
DR JCRB; JCRB1018
DR JCRB; NIHS0252
RX PubMed=6239887;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Discontinued: JCRB; NIHS0252; true.
CC Derived from metastatic site: Left inguinal lymph node.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 10
ST D18S51: 14,17
ST D21S11: 30,32.2
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 11,14
ST D8S1179: 14
ST FGA: 22
ST Penta D: 14
ST Penta E: 17,20
ST TH01: 6
ST TPOX: 11
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HMY-2
AC CVCL_D850
RX PubMed=6239887;
CC Derived from metastatic site: Right inguinal lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HMy.2 B
AC CVCL_8119
SY LICR-Lon-HMy-2; LICR-LON-HMy2; LICR.LON.HMy2; Licr.Lon.Hmy2; Hmy2; LICR-2
DR IMGT/HLA; 10744
DR TKG; TKG 0221
RX PubMed=6582512;
RX PubMed=6864164;
RX PubMed=7140810;
CC Group: Hybridoma fusion partner cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 6,10
ST D13S317: 11,13
ST D16S539: 9,13
ST D5S818: 10,13
ST D7S820: 7,12
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1072 ! ARH-77
SX Female
CA Transformed cell line
//
ID HMy2.A3m
AC CVCL_F825
RX PubMed=2212658;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8119 ! HMy.2 B
SX Female
CA Transformed cell line
//
ID HMy2.C1R
AC CVCL_3714
AS CVCL_E511
SY Hmy.2 CIR; HMy2.CIR; C1R
DR BTO; BTO:0003699
DR CLO; CLO_0003787
DR ATCC; CRL-1993
DR CCRID; 3131C0001000200021
DR dbMHC; 48526
DR ECACC; 94050320
DR IHW; IHW9208
DR IMGT/HLA; 10372
DR Lonza; 1264
RX PubMed=1541831;
RX PubMed=2784569;
RX PubMed=3819393;
WW http://bioinformatics.hsanmartino.it/ecbr/cl208.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-408.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Transformant: NCIt; C44386; Gamma radiation.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 6,10
ST D13S317: 11,13
ST D16S539: 9,13
ST D5S818: 10,13
ST D7S820: 7,12
ST TH01: 8
ST TPOX: 8
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8119 ! HMy.2 B
SX Female
CA Transformed cell line
//
ID HMy2.DRN
AC CVCL_F826
RX PubMed=2212658;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F825 ! HMy2.A3m
SX Female
CA Transformed cell line
//
ID HN
AC CVCL_1283
DR BTO; BTO:0004589
DR CLO; CLO_0003788
DR CLDB; cl1701
DR BioSample; SAMN03473149
DR CCLE; HN_UPPER_AERODIGESTIVE_TRACT
DR ChEMBL-Cells; CHEMBL3308742
DR ChEMBL-Targets; CHEMBL1075465
DR Cosmic; 907059
DR Cosmic-CLP; 907059
DR DSMZ; ACC-417
DR GDSC; 907059
DR GEO; GSM888158
DR GEO; GSM1669887
RX PubMed=8985100;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10
ST D16S539: 12,13
ST D18S51: 13
ST D21S11: 29,30
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 13
ST FGA: 23
ST Penta D: 10,11
ST Penta E: 16
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HN-1
AC CVCL_8123
SY HN1; LICR-LON-HN1
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=7195729;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HN-10
AC CVCL_8124
SY HN10; LICR-LON-HN10
DR Cosmic; 706677
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2183872;
RX PubMed=7195729;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HN-11
AC CVCL_W944
SY HN11; LICR-LON-HN11
DR Cosmic; 706688
DR Cosmic; 2043884
RX PubMed=2183872;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HN-15
AC CVCL_W297
SY HN15; LICR-LON-HN15; LICR-HN-15
DR Cosmic; 686976
RX PubMed=10760816;
RX PubMed=12124801;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HN-16
AC CVCL_EJ04
SY HN16; LICR-LON-HN16
DR Cosmic; 706699
RX PubMed=2183872;
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HN-2
AC CVCL_8125
SY HN2; LICR-LON-HN2; LICR-HN2
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=7195729;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HN-3
AC CVCL_8126
SY HN3; LICR-LON-HN3; LICR (LON) HN-3; LICR-HN-3; LICR-HN3
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=7195729;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HN-4
AC CVCL_8127
SY HN4; LICR-LON-HN4; LICR-HN-4
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=7195729;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HN-5
AC CVCL_8128
SY HN5; LICR-LON-HN5; LICR-HN5; LICR-HN-5; LICR HN-5
DR ChEMBL-Cells; CHEMBL3308481
DR ChEMBL-Targets; CHEMBL614828
DR Cosmic; 686977
DR Cosmic; 706622
DR Cosmic; 916365
DR Cosmic; 1339911
DR Cosmic; 1530740
DR Cosmic; 2131847
DR Cosmic; 2439753
DR GEO; GSM1374540
DR GEO; GSM1374541
DR Lonza; 448
DR NCBI_Iran; C196
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2183872;
RX PubMed=7195729;
RX PubMed=10760816;
RX PubMed=12124801;
RX PubMed=17254797;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Misspelling: 'HNS' in Cosmic 1530740.
ST Source(s): PubMed=17254797; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,11 (PubMed=17254797)
ST CSF1PO: 11,13 (PubMed=21868764)
ST D13S317: 11
ST D16S539: 10,12 (PubMed=17254797)
ST D16S539: 11,13 (PubMed=21868764)
ST D18S51: 12,14
ST D21S11: 27,31
ST D3S1358: 18
ST D5S818: 13
ST D7S820: 11
ST D8S1179: 11,12
ST FGA: 24
ST TH01: 9
ST TPOX: 8,11
ST vWA: 15,18,19
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HN-6
AC CVCL_8129
SY HN6; LICR-LON-HN6; LICR-HN-6; LICR-HN6; LICR-LON-HN6-R
DR Cosmic; 706633
DR Cosmic; 916366
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2183872;
RX PubMed=7195729;
RX PubMed=10760816;
RX PubMed=12124801;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ03 ! HN-6SM
SX Male
CA Cancer cell line
//
ID HN-6SM
AC CVCL_EJ03
SY HN6-SM; LICR-LON-HN6-SM
DR Cosmic; 706644
RX PubMed=2183872;
CC Derived from metastatic site: Submandibular lymph node.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8129 ! HN-6
SX Male
CA Cancer cell line
//
ID HN-7
AC CVCL_8130
SY HN7; LICR-LON-HN7
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=7195729;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HN-8
AC CVCL_8131
SY HN8; LICR-LON-HN8
DR Cosmic; 706655
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2183872;
RX PubMed=7195729;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HN-9
AC CVCL_8132
SY HN9; LICR-LON-HN9
DR Cosmic; 706666
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2183872;
RX PubMed=7195729;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HN-R
AC CVCL_0I56
DR CCLV; CCLV-RIE 1001
RX PubMed=19941903;
OX NCBI_TaxID=9983; ! Lepus europaeus
CA Spontaneously immortalized cell line
//
ID HN-SCC-29
AC CVCL_V279
RX PubMed=3417487;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HN-SCC-68
AC CVCL_V280
RX PubMed=3417487;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HN4
AC CVCL_IS30
SY HN 4
RX PubMed=8603355;
CC Doubling time: 63 hours (PubMed=8603355).
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HN51
AC CVCL_IS31
SY HN 51
RX PubMed=8603355;
RX PubMed=10723130;
CC Doubling time: 75 hours (PubMed=8603355).
CC Derived from metastatic site: Brain.
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNCF-PI 52
AC CVCL_9V83
SY HNCF-pi52
DR NCBI_Iran; C491
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HNE-1
AC CVCL_0308
SY HNE1
DR MCCL; MCC:0000201
DR BioSample; SAMN03472440
RX PubMed=2556716;
RX PubMed=18196576;
CC Problematic cell line: Possibly contaminated. The STR profile is very similar to that of the HelA cell line and almost identical to that of HNE-2 (CVCL_FA07).
CC Characteristics: EBV-negative in established line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=18196576; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,12,13.3
ST D16S539: 9,10 (PubMed=18196576)
ST D16S539: 9,10,11 (PubMed=25877200)
ST D18S51: 13,16
ST D19S433: 13
ST D21S11: 27,30
ST D2S1338: 17,23
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 12,16 (PubMed=18196576)
ST D8S1179: 12,17 (PubMed=25877200)
ST FGA: 18,21
ST Penta D: 9,12
ST Penta E: 17,20
ST TH01: 6,7,9 (PubMed=18196576)
ST TH01: 6,9 (PubMed=25877200)
ST TPOX: 8,12
ST vWA: 14,16
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNE-2
AC CVCL_FA07
SY HNE2
RX PubMed=18196576;
CC Problematic cell line: Possibly contaminated. The STR profile is very similar to that of the HelA cell line and almost identical to that of HNE-1 (CVCL_0308).
ST Source(s): PubMed=18196576
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,12,13.3
ST D16S539: 9,10
ST D18S51: 13,16
ST D19S433: 13
ST D21S11: 27,30
ST D2S1338: 17,23
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 12,16
ST FGA: 18,21
ST TH01: 9
ST TPOX: 8,12
ST vWA: 14,16
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HNE-3
AC CVCL_FA08
SY HNE3
RX PubMed=2556716;
CC Characteristics: EBV-negative.
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HNFF-PI 8
AC CVCL_9V45
DR NCBI_Iran; C172
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HNK-1
AC CVCL_D293
SY HNK1; Leu7
DR CLO; CLO_0003789
DR ATCC; TIB-200
DR BCRJ; 0105
DR NCBI_Iran; H163
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID HNO124
AC CVCL_D207
RX PubMed=12794754;
RX PubMed=20149059;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNO136
AC CVCL_D208
RX PubMed=12794754;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HNO147
AC CVCL_D209
RX PubMed=12794754;
RX PubMed=20149059;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNO150
AC CVCL_D210
RX PubMed=12794754;
RX PubMed=20149059;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HNO160
AC CVCL_D211
RX PubMed=12794754;
RX PubMed=20149059;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HNO180
AC CVCL_D212
RX PubMed=12794754;
RX PubMed=20149059;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNO199
AC CVCL_D213
DR ChEMBL-Cells; CHEMBL3307792
DR ChEMBL-Targets; CHEMBL612257
RX PubMed=12794754;
RX PubMed=20149059;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HNO206
AC CVCL_D214
RX PubMed=12794754;
RX PubMed=20149059;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNO210
AC CVCL_D215
DR CLS; 300134/p1925_HNO210
RX PubMed=12794754;
RX PubMed=20149059;
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 12
ST D5S818: 11,13
ST D7S820: 10
ST TH01: 8.3,9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNO211
AC CVCL_D216
RX PubMed=12794754;
RX PubMed=20149059;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNO212
AC CVCL_D217
RX PubMed=12794754;
RX PubMed=20149059;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HNO222
AC CVCL_D218
RX PubMed=20149059;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HNO223
AC CVCL_D219
DR CLS; 300142/p1926_HNO223
RX PubMed=20149059;
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 12
ST D5S818: 11,13
ST D7S820: 10
ST TH01: 8.3,9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HNO237
AC CVCL_D220
RX PubMed=20149059;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HNO258
AC CVCL_D221
DR CLS; 300146/p4739_HNO258
RX PubMed=20149059;
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 8
ST TH01: 7
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNO268
AC CVCL_D222
RX PubMed=20149059;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HNO306
AC CVCL_D223
RX PubMed=20149059;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HNO41
AC CVCL_D224
DR CLS; 300126/p3774_HNO41
RX PubMed=12794754;
RX PubMed=20149059;
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 8
ST TH01: 7
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNO89
AC CVCL_D225
RX PubMed=12794754;
RX PubMed=20149059;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNO91
AC CVCL_D226
RX PubMed=12794754;
RX PubMed=20149059;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNO97
AC CVCL_D227
SY HNO 97
DR ChEMBL-Cells; CHEMBL3308658
DR ChEMBL-Targets; CHEMBL614808
DR CLS; 300129/p1924_HNO97
RX PubMed=12794754;
RX PubMed=20149059;
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 10,11
ST D5S818: 11,13
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HNOA
AC CVCL_S919
DR CGH-DB; 381-2
DR CGH-DB; 9352-4
RX PubMed=3732924;
RX PubMed=11330945;
RX PubMed=17671176;
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HNOS
AC CVCL_M838
DR JCRB; NIHS0256
RX PubMed=10601556;
CC Discontinued: JCRB; NIHS0256; true.
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HNS1A
AC CVCL_6650
DR RCB; RCB0591
CC Group: Amphibian cell line.
CC Caution: Exact taxonomy is a guess: RIKEN only indicates 'Salamander' as the source. This guess is based on the fact that the provider (Kuro-o Masaki) has worked on Hynobius salamenders including the Japanese Black Salamander whose complete latin name 'Hynobius nigrescens stejnegeri' corresponds to the initials of the strain (HNS).
OX NCBI_TaxID=324339; ! Hynobius nigrescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID HNS2
AC CVCL_6651
DR RCB; RCB0592
CC Group: Amphibian cell line.
CC Caution: Exact taxonomy is a guess: RIKEN only indicates 'Salamander' as the source. This guess is based on the fact that the provider (Kuro-o Masaki) has worked on Hynobius salamenders including the Japanese Black Salamander whose complete latin name 'Hynobius nigrescens stejnegeri' corresponds to the initials of the strain (HNS).
OX NCBI_TaxID=324339; ! Hynobius nigrescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID HNS3
AC CVCL_6652
DR RCB; RCB0593
CC Group: Amphibian cell line.
CC Caution: Exact taxonomy is a guess: RIKEN only indicates 'Salamander' as the source. This guess is based on the fact that the provider (Kuro-o Masaki) has worked on Hynobius salamenders including the Japanese Black Salamander whose complete latin name 'Hynobius nigrescens stejnegeri' corresponds to the initials of the strain (HNS).
OX NCBI_TaxID=324339; ! Hynobius nigrescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID HNS4
AC CVCL_6653
DR RCB; RCB0594
CC Group: Amphibian cell line.
CC Caution: Exact taxonomy is a guess: RIKEN only indicates 'Salamander' as the source. This guess is based on the fact that the provider (Kuro-o Masaki) has worked on Hynobius salamenders including the Japanese Black Salamander whose complete latin name 'Hynobius nigrescens stejnegeri' corresponds to the initials of the strain (HNS).
OX NCBI_TaxID=324339; ! Hynobius nigrescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID HNS5
AC CVCL_6654
DR RCB; RCB0595
CC Group: Amphibian cell line.
CC Caution: Exact taxonomy is a guess: RIKEN only indicates 'Salamander' as the source. This guess is based on the fact that the provider (Kuro-o Masaki) has worked on Hynobius salamenders including the Japanese Black Salamander whose complete latin name 'Hynobius nigrescens stejnegeri' corresponds to the initials of the strain (HNS).
OX NCBI_TaxID=324339; ! Hynobius nigrescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID HNT-34
AC CVCL_2071
SY HNT34
DR CLO; CLO_0050982
DR EFO; EFO_0006583
DR BioSample; SAMN01821631
DR BioSample; SAMN03472915
DR Cosmic; 787435
DR Cosmic; 975253
DR Cosmic; 1012069
DR Cosmic; 1281316
DR Cosmic; 2306209
DR Cosmic; 2378086
DR DSMZ; ACC-600
DR RCB; RCB1296
RX PubMed=9266939;
RX PubMed=16408098;
RX PubMed=25485619;
RX PubMed=25984343;
CC Doubling time: 34 hours (PubMed=25984343); ~40 hours (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
ST Source(s): DSMZ; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 10,11
ST D16S539: 9,12
ST D18S51: 13,16
ST D21S11: 28,32.2
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 8,11
ST D8S1179: 13,14
ST FGA: 20,26
ST Penta D: 10
ST Penta E: 11,14
ST TH01: 6,9
ST TPOX: 11
ST vWA: 14
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID hntES
AC CVCL_4J67
RX Patent=US8647872;
WW http://www.ipscell.com/2014/02/jeanne-lorings-take-on-hwangs-approved-us-patent-of-scnt-embryonic-stem-cells/
WW http://www.ipscell.com/2015/02/mitalipov-hwang/
WW https://www.newscientist.com/article/dn8601-disgraced-cloning-pioneer-could-keep-his-patents/
CC Problematic cell line: As this cell line is reported in a patent originating from authors who have retracted their papers based on the same type of techniques, this cell line origin is doubtful.
CC Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00092.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HNU-Ha-MG1
AC CVCL_HF52
RX PubMed=25678461;
CC Group: Insect cell line.
CC Doubling time: 58.6 +- 7 hours (PubMed=25678461).
OX NCBI_TaxID=29058; ! Helicoverpa armigera
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID HNU-Tn-FB1
AC CVCL_0A12
SY FB1
RX CelloPub=CLPUB00222;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Doubling time: 22.9 hours (CelloPub=CLPUB00222).
OX NCBI_TaxID=7111; ! Trichoplusia ni
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Ho
AC CVCL_M698
SY HO
RX PubMed=2602651;
RX PubMed=2468595;
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HO #1
AC CVCL_1E42
SY HO 1; HO-1
DR BTO; BTO:0002942
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=994214;
RX PubMed=2624919;
CC Derived from metastatic site: Inguinal lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HO(6)
AC CVCL_Y444
DR ATCC; CRL-6267
CC Group: Amphibian cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6267; true.
OX NCBI_TaxID=8400; ! Lithobates catesbeiana
SX Sex undetermined
CA Undefined cell line type
//
ID HO-1-N-1
AC CVCL_1284
SY Ho-1-N-1; HO1-N-1; HO1-N1; Nakata-1
DR BTO; BTO:0005771
DR BioSample; SAMN03472524
DR CGH-DB; 372-2
DR ChEMBL-Cells; CHEMBL3308743
DR ChEMBL-Targets; CHEMBL1075466
DR Cosmic; 924111
DR Cosmic; 1118793
DR Cosmic; 1120708
DR Cosmic; 1530741
DR Cosmic; 1571801
DR Cosmic; 2266787
DR Cosmic-CLP; 924111
DR GDSC; 924111
DR GEO; GSM827187
DR GEO; GSM1669888
DR JCRB; JCRB0831
RX CelloPub=CLPUB00049;
RX PubMed=9290701;
RX PubMed=17599052;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 9,11
ST D5S818: 9
ST D7S820: 10,13
ST TH01: 9
ST TPOX: 11
ST vWA: 16,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HO-1-u-1
AC CVCL_2784
SY HO-1-U-1; Ho-1-u-1; HO1-U-1; HO1-U1; HO1U1; HO1u1; Ho1u1; Ueda-1
DR BTO; BTO:0005948
DR CLO; CLO_0051384
DR BioSample; SAMN01821683
DR BioSample; SAMN03472521
DR Cosmic; 753561
DR Cosmic; 1118792
DR Cosmic; 1120707
DR Cosmic; 1530742
DR Cosmic; 1571800
DR Cosmic; 1995441
DR Cosmic; 2266788
DR Cosmic; 2546834
DR Cosmic-CLP; 753561
DR GDSC; 753561
DR GEO; GSM827216
DR GEO; GSM850381
DR GEO; GSM1669889
DR JCRB; JCRB0828
DR RCB; RCB2102
DR TKG; TKG 0455
RX DOI=10.5794/jjoms.31.1347;
RX PubMed=9290701;
RX PubMed=17325662;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Misspelling: 'HO1-UI' in Cosmic 2546834.
ST Source(s): Cosmic-CLP; JCRB; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9
ST D16S539: 12
ST D5S818: 10
ST D7S820: 9,10
ST TH01: 9
ST TPOX: 10
ST vWA: 17,19
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HO-13-4
AC CVCL_2502
DR CLO; CLO_0003790
DR ATCC; TIB-99
RX PubMed=87465;
CC Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90 (allotype 1.2).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID Ho-15
AC CVCL_HG32
SY HO-15
DR TOKU-E; 3611
RX PubMed=10764804;
CC Characteristics: Established from a G6pc deficient mouse.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [A255].
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID HO-2.2
AC CVCL_2503
DR CLO; CLO_0003791
DR ATCC; TIB-150
CC Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID HO-22-1
AC CVCL_2504
DR CLO; CLO_0003792
DR ATCC; TIB-100
RX PubMed=87465;
CC Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90 (allotype 1.1).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID HO-23
AC CVCL_0309
SY HO23
DR MCCL; MCC:0000202
RX PubMed=9794480;
RX PubMed=15541573;
CC Transfected with: HGNC; 11998; TP53 (with V-135).
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HO-323
AC CVCL_Z045
SY HO 323/WIL2.NS; HO323
RX PubMed=3485476;
CC Group: Hybridoma fusion partner cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2761 ! WIL2 NS
SX Male
CA Transformed cell line
//
ID HO-8910
AC CVCL_6868
SY Ho-8910; HO8910; Ho8910
DR BTO; BTO:0005438
DR CCRID; 3111C0001CCC000280
DR CCRID; 3131C0001000700024
RX PubMed=8082435;
RX PubMed=11930655;
RX PubMed=25502083;
CC Omics: Transcriptome analysis.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HO-8910PM
AC CVCL_0310
SY HO-8910 PM; HO8910/PM; HO8910PM; HO8910pm
DR BTO; BTO:0005772
DR MCCL; MCC:0000203
DR CCRID; 3111C0001CCC000281
DR CCRID; 3131C0001000700025
RX PubMed=10464713;
RX PubMed=11930655;
RX PubMed=25502083;
CC Doubling time: 34.5 hours (PubMed=10464713).
CC Omics: Transcriptome analysis.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6868 ! HO-8910
SX Female
CA Cancer cell line
- 公告/新闻
